Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Takeda Pharmaceutical has acquired PvP Biologics, a San Diego, California-based pharmaceutical company developing treatments for celiac disease, in a deal worth up to $330 million. The acquisition follows the conclusion of a Phase I proof-...

A roundup of developments from Malaysia (Biocon), Saudi Arabia (Grifols), UK (AstraZeneca), and the US (Merck & Co., Taro Pharmaceuticals). Malaysia Biocon Receives FDA Form 483 for Insulin Mfg Plant in Malaysia The US Food and Drug...

GlaxoSmithKline (GSK) has agreed to sell to Stada, a Bad Vilbel, Germany-based company, a portfolio of 15 local and regional consumer healthcare brands in countries predominantly in Europe for an undisclosed amount. The portfolio includes cold and...

Sanofi plans to create a new European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (APIs). Sanofi expects the new manufacturing company to bring in EUR 1 billion ($1.1 billion) in sales by...